1. Home
  2. VRTS vs CDNA Comparison

VRTS vs CDNA Comparison

Compare VRTS & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Investment Partners Inc.

VRTS

Virtus Investment Partners Inc.

HOLD

Current Price

$145.78

Market Cap

968.0M

Sector

Finance

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$22.86

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRTS
CDNA
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
968.0M
1.1B
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
VRTS
CDNA
Price
$145.78
$22.86
Analyst Decision
Hold
Buy
Analyst Count
4
6
Target Price
$158.00
$28.00
AVG Volume (30 Days)
71.5K
583.8K
Earning Date
05-01-2026
04-28-2026
Dividend Yield
6.68%
N/A
EPS Growth
18.24
N/A
EPS
1.05
0.05
Revenue
N/A
$48,324,000.00
Revenue This Year
N/A
$16.01
Revenue Next Year
$1.66
$11.31
P/E Ratio
$134.60
$455.40
Revenue Growth
N/A
18.93
52 Week Low
$121.61
$10.96
52 Week High
$214.88
$23.24

Technical Indicators

Market Signals
Indicator
VRTS
CDNA
Relative Strength Index (RSI) 54.35 65.92
Support Level $134.54 $15.80
Resistance Level $147.15 $22.89
Average True Range (ATR) 4.88 0.95
MACD 0.22 0.11
Stochastic Oscillator 76.21 90.52

Price Performance

Historical Comparison
VRTS
CDNA

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: